A comparison of immunotoxic effects of nanomedicinal products with regulatory immunotoxicity testing requirements

Christina Giannakou*, Margriet V. D. Z. Park, Wim H. de Jong, Henk van Loveren, Rob J. Vandebriel, Robert E. Geertsma

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)2935-2952
JournalInternational Journal of Nanomedicine
Volume11
DOIs
Publication statusPublished - 2016

Keywords

  • nanomedicine
  • regulatory requirements
  • safety
  • testing methods
  • immunotoxicity

Cite this